Loading clinical trials...
Loading clinical trials...
Use of Meditation as a Complementary Therapy in the Treatment of Gestational Hypertension
Pregnancy relates to arterial hypertension; it is an aggravating factor for pre-existing chronic arterial hypertension or a trigger for preeclampsia in normotensive women. The gestational hypertensive disease is managed conventionally with the pregnant woman's hospitalization and/or the use of antihypertensive medications. Nevertheless, this treatment may present some risks. The investigators seek to determine whether the intervention compared to the control can reduce the increase in blood pressure that pregnant women in the transition from the 2nd to the 3rd trimester.
Primary research question: Can meditation decrease the mean increase in diastolic blood pressure in pregnant hypertensive women at the transition from the second to the third trimester of gestation? Secondary research question: Can meditation decrease the mean increase in systolic blood pressure in pregnant hypertensive women at the transition from the second to the third trimester of gestation? Does meditation practice increases (or decreases) the likelihood of change in Resilience indicators? Does meditation practice increase (or decrease) the likelihood of change in anxiety and depression indicators? Does meditation practice increase (or decrease) the likelihood of change in mindfulness indicators? Does meditation practice increase (or decrease) the likelihood of change in quality of life indicators?
Age
21 - 50 years
Sex
FEMALE
Healthy Volunteers
No
Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
São Paulo, Brazil
Start Date
April 15, 2019
Primary Completion Date
December 15, 2021
Completion Date
December 30, 2021
Last Updated
March 24, 2022
47
ACTUAL participants
Meditation
OTHER
conventional treatment
OTHER
Lead Sponsor
University of Sao Paulo General Hospital
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions